SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

(2022) Nicole Wolter et al.   LANCET

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant

(2022) Roby P. Bhattacharyya et al.   NEW ENGLAND JOURNAL OF MEDICINE

Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis

(2021) Asma Boumaza et al.   JOURNAL OF INFECTIOUS DISEASES

COVID-19 and the human innate immune system

(2021) Joachim L. Schultze et al.   CELL

Pharmacological activation of STING blocks SARS-CoV-2 infection

(2021) Minghua Li et al.   Science Immunology

The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus

(2021) Ying Liu et al.   JOURNAL OF TRAVEL MEDICINE

Retinoic Acid Inducible Gene-I like Receptors Activate Snail to Limit RNA Viral Infections

(2021) Dhiviya Vedagiri et al.   JOURNAL OF VIROLOGY

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

(2021) Katherine A Twohig et al.   LANCET INFECTIOUS DISEASES

Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape

(2021) Mary Bushman et al.   CELL

Waning Immunity after the BNT162b2 Vaccine in Israel

(2021) Yair Goldberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential

(2021) Divya Gupta et al.   VIRUS RESEARCH

SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis

(2021) Ji-Seung Yoo et al.   Nature Communications

Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar

(2021) Adeel A. Butt et al.   JAMA Internal Medicine

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization

(2021) Li Zhang et al.   Communications Biology

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era

(2021) Stephen Y Wang et al.   Lancet Microbe

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

On the origin and continuing evolution of SARS-CoV-2

(2020) Xiaolu Tang et al.   National Science Review

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

(2020) Daniel Blanco-Melo et al.   CELL

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

(2020) Jérôme Hadjadj et al.   SCIENCE

Activation and evasion of type I interferon responses by SARS-CoV-2

(2020) Xiaobo Lei et al.   Nature Communications

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.

(2020) Kumari G. Lokugamage et al.   JOURNAL OF VIROLOGY

Evasion of Type I Interferon by SARS-CoV-2

(2020) Hongjie Xia et al.   Cell Reports

Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison

(2020) Ioanna-Evdokia Galani et al.   NATURE IMMUNOLOGY

Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype

(2019) Daehwan Kim et al.   NATURE BIOTECHNOLOGY

The phylogenomics of evolving virus virulence

(2018) Jemma L. Geoghegan et al.   NATURE REVIEWS GENETICS

Control of adaptive immunity by the innate immune system

(2015) Akiko Iwasaki et al.   NATURE IMMUNOLOGY

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

(2013) Y. Liao et al.   BIOINFORMATICS